As a small heavy glycosylated antigen that overexpressed in ovarian carcinoma, CD24 expression is associated with the development, invasion, metastasis of cancers, as well as the immune evasion, which also gained increasing interest in the ovarian cancer therapy field (5). This evidence concerns the gene CD24 and cancer.